Bosentan and dapagliflozin clinical trials

Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)

This study looks at how two medicines, Bosentan and dapagliflozin, might help people with a condition called Large Vessel Vasculitis (LVV). LVV damages blood vessels, increasing risks like heart attacks. We want to see if these medicines can improve blood vessel health.